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Opioid Use, Abuse and Treatment
 Opiates are a frequently prescribed medication for the treatment of 
pain, particularly in the post-operative setting (1).
 Higher rates of opioid analgesic prescription are associated with higher 
rates of opoid abuse and addiction (2).
 Opioid abuse in Vermont is an epidemic; 6% of 12-17 year olds, 12% of 
18-25 year olds, and 3% of people 26 years or older report non-medical 
use of prescription pain killers as of 2012 (3).
 Medically assisted treatment (MAT) of Opioid Addiction is associated 
with increased quality of life (4), and its use is becoming more widely 
accepted among providers in ambulatory treatment centers (5).
 Vermont has adopted a “Hub and Spoke” model of substance abuse 
MAT in which the level of intervention and supervision is titrated to the 
risk profile of the patient (6).
Economic Burden of Opioid Abuse
 As of 2007, Birnbaum et al. (7) estimated that the annual societal 
costs of opiate prescription abuse in the United States was $55.7 
billion.
 These costs included:
 Lost productivity in the workforce ($25.6 billion)
 Healthcare expenses ($25 billion)
 Expenses related to the criminal justice system ($5.1 billion) 
Community Perspectives
 Suboxone patients, on how they first started using opiates:
 “My girlfriend and I just thought, what the hell, let’s try it. It was great, and we started using 
more and more often. Before long though, the pills were getting too expensive and someone 
suggested I try heroine instead. It works, and it’s cheap, but it leaves me feeling like I’m 
disgusting. I don’t think people know how much I’m using.”
 “I started using in College. I tried to quit a few times, but last time I relapsed they caught me 
driving and I lost my license. I’ve been having to ask people for rides down to Boston and 
back once a month to go to a Suboxone clinic down there.”
 Local Physician
 “The numbers are just too high (looking at rates of adolescent opiate use in VT). Everyone has 
been affects in some way, either they themselves, or someone in their family. Even if they 
don’t know they know someone. That’s why we’re trying to expand the amount of Suboxone
treatment that we do here at CHCRR”
 Member of Brandon Cares community group
 “It’s such an incredibly huge problem, not just in Vermont, but everywhere. The cousin of one 
of the women here in town lost both of her sons on the same day to opiate overdose. Really 
sad. That’s the really scary part about the drugs on the street, no one knows what they’re 
laced with or what’s in them or what.”
Intervention and Methodology
 Review of currently available resources and information regarding 
opiate abuse and its treatment in Vermont
 Creation of a single, easily digestible pamphlet for providing 
information to opiate abusers that are considering treatment for 
their addictions
 This pamphlet includes:
 An overview of opiate abuse in Vermont
 Introduction to the “Hub and Spoke” MAT system in Vermont
 Consolidated list of treatments centers specializing in substance abuse 
and licensed alcohol and drug abuse counselors in the area
Response
 The response from care providers at the Brandon Medical Center 
was positive. Physicians expressed enthusiasm at having a 
consolidated informational handout to either leave in the waiting 
room or to give to patients directly.
Effectiveness and Limitations
 The purpose of this project was to provide a safe, low threshold source of 
information to people considering treatment for opiate addiction. Since the 
pamphlet’s use is designed to be, at least in part, anonymous, it is difficult to 
directly assess its effectiveness. That said there are two ways to assess whether 
the pamphlet is being used:
 Checks on how quickly pamphlets are being taken from the waiting room
 Asking new enrollees into the suboxone program how they first became aware of the 
“hub and spoke” system
 This pamphlet represents one more in a long list of potential routes toward 
treatment. Whether it is responsible for simply planting the seed in a person’s 
mind or for being the final straw that gets that person to call in for help is not 
important.
 “If this ends up helping even just one person, it will be time well spent.”
 Limitations: This pamphlet is primarily targeted towards the patient population 
seen at the Brandon Medical Center, and therefore only includes specific 
informational listings for Addison and Rutland County
Future Interventions
 In the future, it would be useful to gather information about how 
those patients that do actually become enrolled in MAT programs 
first learn about the programs, what it was that made them want to 
become involved, and what was difficult about the steps in 
becoming enrolled.
 With this information, providers may be better equipped to lower the 
threshold for potential enrollees to reach out for help. 
 Susan Roy of the Brandon Cares group and Amy Kitteridge, a LADC 
at the Brandon Medical Center, are both useful contacts.
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